English
Segment disclosures
Company overviewHEALTHY EXTRACTS INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
5 dimension combinations 29 retained observations 16 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Advertising
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=grck:AdvertisingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 120500 | USD | 20180608 | Open filing evidence |
CBD
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=grck:CBDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-07-01 – 2018-09-30 | 15203 | USD | 20190425 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 66119 | USD | 20190425 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 31060 | USD | 20180911 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 50916 | USD | 20180911 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 19856 | USD | 20180713 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 7605 | USD | 20180608 | Open filing evidence |
Health Supplements
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=grck:HealthSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-03-31 | 455839 | USD | 20200814 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 748377 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 273302 | USD | 20200601 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 571615 | USD | 20200601 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 201040 | USD | 20200529 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 298313 | USD | 20200529 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 97273 | USD | 20200528 | Open filing evidence |
Health Supplements · Berga Met
Statement Business Segments · Business Acquisition
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=grck:HealthSupplementsMember;us-gaap:BusinessAcquisitionAxis=grck:BergaMetMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 170433 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 135902 | USD | 20210219 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1276559 | USD | 20210219 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 533099 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1140657 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 151719 | USD | 20200915 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 607558 | USD | 20200915 | Open filing evidence |
Health Supplements · Berga Met
Statement Business Segments · Business Acquisition
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hyex:HealthSupplementsMember;us-gaap:BusinessAcquisitionAxis=hyex:BergaMetMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 766372 | USD | 20220401 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1676598 | USD | 20220401 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 447986 | USD | 20211115 | Open filing evidence |
| 2021-04-01 – 2021-09-30 | 903142 | USD | 20211115 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 414318 | USD | 20210903 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 170433 | USD | 20210803 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 135902 | USD | 20210803 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1276559 | USD | 20210803 | Open filing evidence |